Drawing for ODXI-IBC

USPTO serial 88278751

ODXI-IBC

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WATSON, BRIDGET ANNE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ODXI-IBC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Margaret McHugh

MARGARET C. MCHUGH KILPATRICK TOWNSEND & STOCKTON LLP1100 PEACHTREE STREET NE 2800MAILSTOP IP DOCKETING 22ATLANTA, GA 30309

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples for use in cancer detection, analysis and prognosis; medical diagnostic reagents; diagnostic kits consisting primarily of enzymes for medical purposes, nucleic acids, buffers, reagents and assays for use in disease testing; medical diagnostic assays for testing tissue for medical and prognostic purposes; medical diagnostic reagents and assays for testing tissue samples for use in disease detection, namely, cancer; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer for medical purposes; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the diagnosis, analysis and prognosis of cancer for medical purposes; diagnostic agents, preparations and substances for medical purposesACTIVE—
044Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classificationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 2, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 2, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 30, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 30, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 29, 2019ALIEASSIGNED TO LIE—
Apr 17, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 17, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Apr 17, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 17, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 17, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 9, 2019DOCKASSIGNED TO EXAMINER—
Feb 20, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 31, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance